Research and Development

Showing 15 posts of 9573 posts found.

Xceleron's Dr Graham Lappin

Talking R&D: Microdosing studies

January 18, 2010 Research and Development Microdosing, Talking R&D, Xceleron

A microdose study is performed at an early stage of development in order to obtain preliminary pharmacokinetic or distribution data …
Pfizer

Pfizer signs ‘personalised’ cancer collaboration

January 15, 2010 Research and Development Cancer, Debiopharm, Pfizer, melanoma, skin cancer, tremelimumab

Pfizer is to co-develop its monoclonal antibody treatment for advanced melanoma with Swiss company Debiopharm. The companies will conduct phase …

AstraZeneca taps Korean firm for antibiotics

January 15, 2010 Research and Development Asia, AstraZeneca, CrystalGenomics, Korea, anti-infectives

AstraZeneca has signed another licensing deal to bolster its anti-infectives business, this time signing a deal with Korean company CrystalGenomics …
SWest_2009

MDS promotes Steve West to chief executive

January 14, 2010 Research and Development appointment, mds, research and development

Canadian clinical research firm MDS has appointed Steve West chief executive. He was formerly president of MDS Nordion and chief …

FDA begins consumer transparency initiative

January 13, 2010 Research and Development, Sales and Marketing FDA, transparency

The Food and Drug Administration has unveiled the first phase of its transparency initiative, designed to make its drug approval …

Joseph Zakrzewski, executive chairman, Amarin

January 13, 2010 Research and Development Amarin, appointment, research and development

Dublin-headquartered biotech Amarin has appointed Joseph Zakrzewski executive chairman. He is currently the chief executive of Xcellerex, a Massachusetts-based biotechnology …

Sanofi Pasteur collaborates on novel biologics

January 12, 2010 Research and Development KaloBios, Sanofi, Sanofi Pasteur, cystic fibrosis, infection, vaccines

Sanofi Aventis’ vaccines division has partnered with US biotech KaloBios to develop a number of novel biologic treatments. Sanofi Pasteur …

Signs of product payoff from GSK’s $1.5bn alliance

January 12, 2010 Research and Development ChemoCentryx, Crohn's, GlaxoSmithKline

GlaxoSmithKline is to develop and commercialise a drug which hopes will be a treatment for moderate-to-severe Crohn’s disease. Californian biotech …
FDA’s Deputy Commissioner for International Programs Murray Lumpkin

Transatlantic conversations

January 11, 2010 Research and Development EMA, FDA

The Pharmafocus interview: Murray Lumpkin, FDA Deputy Commissioner for International ProgramsCollaborations between the world’s leading medicines regulators have increased markedly …

Michael Moore, chairman, Oxford BioTherapeutics

January 11, 2010 Research and Development Oxford Biotherapeutics, Piramed, appointment, research and development

Oxford BioTherapeutics (OBT) has appointed Dr Michael Moore non-executive chairman. He joins the company following five years spent at UK …

Roche signs genetic chemistry technology deal

January 11, 2010 Research and Development Evolva, Roche, genetic chemistry

Roche has signed a deal with Evolva Holding to create anti-infectives and cancer treatments using the latter’s genetic chemistry technology. Roche’s …

Alison Clough promoted to commercial and communications director for the ABPI

January 11, 2010 Medical Communications, Research and Development, Sales and Marketing ABPI, appointment, patent box

UK pharma industry association the ABPI has promoted Alison Clough to commercial and communications director. She moves into the new …

Marksans presses on with plan to exit API business

January 11, 2010 Manufacturing and Production, Research and Development API, Marksans

India’s Marksans Pharma is seeking approval from its shareholders to divest or lease out its two active pharmaceutical ingredient (API) …
Eisai's manufacturing and research facility in South India

Eisai looks to India for API production

January 8, 2010 Manufacturing and Production, Research and Development Eisai, India

Japanese drugmaker Eisai has started operations at a manufacturing and research facility in Visakhapatnam, southern India, which will be the …

Stephen Cutler, chief operating officer, Kendle

January 8, 2010 Research and Development Kendle, appointment, research and development

Kendle has appointed Stephen Cutler to the position of senior vice president and chief operating officer.Dr Cutler has a track …
The Gateway to Local Adoption Series

Latest content